Cordarone combined with Digoxin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Ventricular Extrasystoles Life Threatening 12/8/2005 82 Male 1/30/2006 Consumer France
Primary
Secondary
Concomitant
Syncope Hospitalization 1/22/2006 58 Female 3/1/2006 Other Health Professional France
Primary
Concomitant
Interacting
Pulmonary Alveolar Haemorrhage Hospitalization 12/21/2005 85 Male 3/10/2006 France
Primary
Concomitant
Overdose Hospitalization 1/23/2006 28 Female 3/2/2006 France
Primary
Secondary
Concomitant
Visual Evoked Potentials Abnormal Other Serious 9/25/2005 51 Male 3/21/2006 Other Health Professional Germany
Primary
Concomitant
Lymphadenopathy Mediastinal Hospitalization 11/1/2004 68 Male 3/30/2006 Other Health Professional France
Primary
Secondary
Concomitant
Renal Failure Hospitalization 12/30/2005 74 Male 154 lb 4/5/2006 Other Health Professional France
Primary
Concomitant
Interacting
Polymyalgia Rheumatica Other Serious 3/1/2006 91 Male 126 lb 3/28/2006 Physician United States
Primary
Secondary
Concomitant
Nodal Arrhythmia Other Serious 10/27/2005 82 Female 4/4/2006 France
Primary
Secondary
Concomitant
Prothrombin Time Ratio Decreased Hospitalization 2/12/2006 95 Male 4/21/2006 Other Health Professional France
Primary
Concomitant
Urinary Incontinence Hospitalization 3/9/2006 63 Female 209 lb 5/1/2006
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Hospitalization 12/30/2005 74 Male 154 lb 5/2/2006 Other Health Professional France
Primary
Concomitant
Interacting
Ventricular Hypertrophy Other Serious 9/1/2005 65 Male 152 lb 5/2/2006 Physician Switzerland
Primary
Secondary
Concomitant
Urinary Incontinence Other Serious 3/1/2006 63 Female 5/13/2006 France
Primary
Secondary
Concomitant
International Normalised Ratio Increased Other Serious 4/21/2006 68 Female 6/6/2006 France
Primary
Secondary
Concomitant
Vomiting Other Serious 4/21/2006 68 Female 6/9/2006 France
Primary
Secondary
Concomitant
Vomiting Hospitalization 5/27/2006 75 Female 7/5/2006 Other Health Professional France
Primary
Secondary
Concomitant
Lichenoid Keratosis Hospitalization 6/15/2000 72 Female 7/21/2006
Primary
Secondary
Concomitant
Lichenoid Keratosis Hospitalization 6/15/2000 72 Male 7/31/2006 France
Primary
Secondary
White Blood Cell Count Increased Hospitalization 12/1/2005 55 Female 8/9/2006 France
Primary
Secondary
Concomitant
Syncope Hospitalization 1/23/2006 58 Female 8/1/2006 Other Health Professional France
Primary
Secondary
Concomitant
Pulmonary Oedema Hospitalization 11/14/1998 73 Male 8/15/2006 France
Primary
Concomitant
Malaise Hospitalization 6/1/2006 82 Female 154 lb 8/10/2006 Physician France
Primary
Secondary
Concomitant
Skin Exfoliation Other Serious 12/27/2005 55 Female 8/18/2006 Other Health Professional France
Primary
Secondary
Concomitant
Respiratory Arrest Hospitalization 4/4/2005 61 Male 8/24/2006 Consumer France
Primary
Concomitant
Malaise Hospitalization 1/1/2006 82 Female 8/21/2006 Other Health Professional France
Primary
Secondary
Concomitant
Blood Amylase Increased Other Serious 5/1/2005 78 Male 9/5/2006 United Kingdom
Primary
Concomitant
Heart Rate Decreased Other Serious 7/9/2006 85 Female 9/28/2006 France
Primary
Secondary
Concomitant
Urinary Incontinence Hospitalization 8/23/2005 82 Male 10/5/2006 France
Primary
Concomitant
Bronchospasm Life Threatening 4/26/2006 37 Female 10/27/2006 Consumer Japan
Primary
Concomitant
Prostate Cancer Life Threatening 1/1/1996 72 Male 150 lb 10/27/2006 Physician Ireland
Primary
Concomitant
Stevens-johnson Syndrome Hospitalization 8/22/2006 60 Male 11/2/2006 Ukraine
Primary
Secondary
Concomitant
Pulmonary Fibrosis Hospitalization 5/1/2004 79 Male 11/8/2006 France
Primary
Concomitant
Medication Error Death 1/1/2005 86 11/13/2006 United States
Primary
Secondary
Medication Error Death 1/1/2005 82 Unknown 11/13/2006 Physician United States
Primary
Secondary
Medication Error Death 1/1/2005 86 Unknown 11/13/2006 United States
Primary
Secondary
Medication Error Death 1/1/2005 82 11/13/2006 United States
Primary
Secondary
Stevens-johnson Syndrome Hospitalization 7/1/2006 60 Male 11/17/2006 Ukraine
Primary
Secondary
Concomitant
Pleural Effusion Hospitalization 9/1/2006 64 Male 11/21/2006 France
Primary
Secondary
Concomitant
Sudden Death Death 9/17/2006 85 Female 12/16/2006 France
Primary
Secondary
Cardioactive Drug Level Increased Other Serious 9/24/2006 81 Male 12/11/2006 France
Primary
Secondary
Concomitant
Sudden Death Death 9/17/2006 85 Female 12/21/2006 France
Primary
Secondary
Vomiting Other Serious 10/12/2006 Female 12/29/2006 Physician France
Primary
Secondary
Concomitant
Drug Interaction Other Serious 8/31/2006 74 Male 1/11/2007 Sweden
Primary
Secondary
Concomitant
Off Label Use Hospitalization 12/1/2006 86 Male 1/24/2007 Physician France
Primary
Concomitant
Neutropenia Hospitalization 12/18/2006 70 Male 1/29/2007 Other Health Professional France
Primary
Secondary
Concomitant
Prothrombin Time Prolonged Hospitalization 9/29/2006 86 Female 95 lb 2/2/2007 Other Health Professional Switzerland
Primary
Concomitant
Interacting
Mutism Other Serious 86 Female 154 lb 1/30/2007 Consumer Brazil
Primary
Secondary
Concomitant
Vaginal Haemorrhage Hospitalization 10/31/2006 86 Female 2/16/2007 Other Health Professional France
Primary
Concomitant
Interacting
Shock Haemorrhagic Hospitalization 12/1/2006 87 Male 3/9/2007 Physician France
Primary
Concomitant
Hyperthyroidism Other Serious 2/1/2007 63 Male 4/3/2007 Other Health Professional France
Primary
Concomitant
Retinopathy Other Serious 3/1/2006 Female 4/18/2007 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Neutropenia Hospitalization 12/18/2006 70 Male 4/24/2007 Other Health Professional France
Primary
Secondary
Concomitant
Pulmonary Fibrosis Hospitalization 2/1/2007 86 Female 4/18/2007 France
Primary
Secondary
Concomitant
Electrocardiogram Qt Prolonged Hospitalization 2/10/2007 83 Male 5/3/2007 Other Health Professional France
Primary
Secondary
Concomitant
Retinopathy Other Serious 3/1/2006 Female 5/14/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Chest Discomfort Hospitalization 4/1/2007 75 Male 5/7/2007 Consumer United States
Primary
Concomitant
Skin Exfoliation Hospitalization 2/26/2007 77 Female 5/18/2007 Other Health Professional France
Primary
Secondary
Chest Discomfort Hospitalization 4/1/2007 75 Male 5/17/2007 Consumer United States
Primary
Concomitant
Haemoglobin Decreased 7/1/2006 61 Male 6/26/2007 Other Health Professional United States
Primary
Concomitant
Drug Interaction Hospitalization 5/16/2007 Female 6/28/2007 Other Health Professional France
Primary
Concomitant
Interacting
Transaminases Increased Hospitalization 6/22/2007 95 Female 7/12/2007 Pharmacist France
Primary
Concomitant
Bradycardia Life Threatening 5/19/2007 93 Male 126 lb 7/9/2007 Physician France
Primary
Concomitant
Hypokalaemia Hospitalization 5/23/2007 Male 7/26/2007 Other Health Professional France
Primary
Secondary
Concomitant
Pulmonary Oedema Life Threatening 6/6/2007 Male 132 lb 7/30/2007 Physician France
Primary
Secondary
Concomitant
Thrombocytopenia Hospitalization 10/1/2006 58 Male 209 lb 8/7/2007 Physician France
Primary
Concomitant
Hyperthyroidism Other Serious 2/1/2007 63 Male 8/9/2007 Other Health Professional France
Primary
Concomitant
Nausea Hospitalization 1/1/2007 Male 8/13/2007 Other Health Professional United Kingdom
Primary
Concomitant
Renal Failure Acute Hospitalization 6/26/2007 61 Male 377 lb 8/24/2007
Primary
Secondary
Concomitant
Pulmonary Fibrosis Other Serious 7/28/2007 Male 9/6/2007 Other Health Professional Philippines
Primary
Concomitant
Nausea Hospitalization 1/1/2007 Male 9/7/2007 Other Health Professional United Kingdom
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 6/14/2007 79 Male 9/11/2007 Other Health Professional France
Primary
Secondary
Concomitant
Ocular Hyperaemia Disability 11/1/2005 85 Male 142 lb 8/31/2007 Other Health Professional United States
Primary
Concomitant
Nausea Hospitalization 6/14/2007 Male 9/20/2007 Other Health Professional France
Primary
Concomitant
Interacting
International Normalised Ratio Increased Hospitalization 8/3/2007 83 Female 168 lb 9/24/2007 Consumer France
Primary
Secondary
Concomitant
Visual Field Defect Other Serious 9/1/2001 Male 160 lb 9/25/2007 Lawyer United States
Primary
Secondary
Concomitant
International Normalised Ratio Increased Hospitalization 4/11/2007 Female 9/25/2007 Physician France
Primary
Concomitant
International Normalised Ratio Increased Hospitalization 8/3/2007 83 Female 9/27/2007 Other Health Professional France
Primary
Concomitant
Interacting
Visual Field Defect Other Serious 9/1/2001 Male 160 lb 10/5/2007 Lawyer United States
Primary
Secondary
Concomitant
Ocular Hyperaemia Disability 11/1/2005 85 Male 153 lb 9/27/2007 Other Health Professional United States
Primary
Concomitant
Thrombocytopenia Life Threatening 2/19/1999 89 Female 10/11/2007 Consumer France
Primary
Concomitant
Hypertensive Heart Disease Death 78 Female 132 lb 11/1/2007 Physician Algeria
Primary
Concomitant
International Normalised Ratio Abnormal Hospitalization 9/16/2007 38 Female 11/13/2007 Other Health Professional France
Primary
Concomitant
Hyponatraemia Hospitalization 10/1/2007 Female 11/16/2007 Other Health Professional France
Primary
Secondary
Renal Failure Hospitalization 9/20/2007 Female 11/15/2007 Consumer France
Primary
Concomitant
Hyponatraemia Hospitalization 10/1/2007 Female 11/27/2007 Other Health Professional France
Primary
Secondary
Faeces Discoloured 1/1/2007 63 Male 172 lb 12/17/2007 United States
Primary
Concomitant
Thrombocytopenia Hospitalization 4/10/2007 71 Male 154 lb 12/4/2007 Other Health Professional France
Primary
Concomitant
Parkinsonism Hospitalization 10/14/2007 97 Female 12/21/2007 France
Primary
Secondary
Concomitant
Parkinsonism Hospitalization 10/14/2007 97 Female 12/28/2007 France
Primary
Secondary
Concomitant
Thrombocytopenia Hospitalization 11/18/2007 58 Male 1/8/2008 Other Health Professional France
Primary
Secondary
Concomitant
Toxic Skin Eruption Hospitalization 5/3/2007 74 Female 1/4/2008 Other Health Professional France
Primary
Secondary
Concomitant
Hypothyroidism Hospitalization 11/19/2001 50 Male 1/24/2008 United States
Primary
Concomitant
Paraesthesia Other Serious 1/1/2004 64 Female 138 lb 1/24/2008 Physician United States
Primary
Concomitant
Lung Disorder Hospitalization 11/1/2007 79 Female 2/18/2008 Physician France
Primary
Concomitant
Tremor Hospitalization 2/22/2008 80 Female 3/6/2008 Pharmacist France
Primary
Concomitant
White Blood Cell Count Decreased Hospitalization 4/10/2007 71 Male 154 lb 3/17/2008 Other Health Professional France
Primary
Concomitant
Dyspnoea Hospitalization 3/7/2008 67 Female 4/1/2008 Physician Thailand
Primary
Secondary
Concomitant
Tremor Hospitalization 2/22/2008 80 Female 4/24/2008 Pharmacist France
Primary
Concomitant
Tremor 9/1/2007 82 Female 160 lb 4/10/2008 Consumer United States
Primary
Concomitant
Visual Field Defect Other Serious 9/1/2001 Male 159 lb 6/20/2008 Lawyer United States
Primary
Secondary
Concomitant
Polydipsia Other Serious 4/8/2008 71 Female 6/23/2008 Other Health Professional France
Primary
Concomitant
Overdose Hospitalization 1/3/2008 53 Male 6/25/2008 Other Health Professional France
Primary
Secondary
Concomitant
Overdose Hospitalization 1/3/2008 53 Male 6/30/2008 Other Health Professional France
Primary
Secondary
Concomitant
Hepatitis Fulminant Life Threatening 4/2/2008 Male 7/2/2008 Other Health Professional France
Primary
Secondary
Concomitant
Peripheral Ischaemia Death 5/24/2008 76 Female 7/3/2008
Primary
Secondary
Concomitant
Toxic Skin Eruption Life Threatening 3/27/2008 65 Male 7/7/2008 Consumer France
Primary
Secondary
Concomitant
Pleuropericarditis Death 12/22/2007 75 Female 7/16/2008 Other Health Professional France
Primary
Secondary
Concomitant
Overdose Life Threatening 4/6/2008 Male 7/23/2008 Other Health Professional France
Primary
Concomitant
Interacting
Renal Failure Acute Life Threatening 2/22/2008 80 Female 8/1/2008 Other Health Professional France
Primary
Concomitant
Interacting
Polydipsia Other Serious 4/8/2008 71 Female 9/4/2008 Other Health Professional France
Primary
Concomitant
Disease Progression Hospitalization 8/27/2008 Female 126 lb 9/16/2008 France
Primary
Concomitant
Myalgia Other Serious Male 10/1/2008 Physician Switzerland
Primary
Secondary
Concomitant
Paraesthesia 81 Female 125 lb 10/7/2008 United States
Primary
Concomitant
Drug Prescribing Error Hospitalization 7/25/2008 79 Female 183 lb 10/21/2008 Other Health Professional France
Primary
Concomitant
Interacting
Therapeutic Agent Toxicity Hospitalization 76 Female 11/4/2008 United States
Primary
Concomitant
Weight Decreased Hospitalization 11/19/2008 78 Male 12/2/2008 Other Health Professional United Kingdom
Primary
Concomitant
Lichenoid Keratosis Hospitalization 6/15/2000 72 Female 12/22/2008
Primary
Secondary
Concomitant
Rash Erythematous Hospitalization 6/15/2000 72 Male 12/23/2008 Other Health Professional France
Primary
Secondary
Concomitant
Drug Interaction Hospitalization 9/29/2008 64 Female 12/30/2008 Other Health Professional France
Primary
Concomitant
Interacting
Therapeutic Agent Toxicity Other Serious 50 Male 12/29/2008 Lawyer United States
Primary
Concomitant
Therapeutic Agent Toxicity Other Serious 50 Male 12/29/2008 United States
Primary
Concomitant
Toxic Epidermal Necrolysis Death 11/25/2008 62 Female 163 lb 1/23/2009 Consumer France
Primary
Secondary
Concomitant
Dermatitis Exfoliative Hospitalization 11/21/2008 Male 1/27/2009 Other Health Professional France
Primary
Secondary
Concomitant
Toxic Epidermal Necrolysis Death 11/25/2008 62 Female 163 lb 1/27/2009 Consumer France
Primary
Secondary
Concomitant
Toxic Epidermal Necrolysis Hospitalization 11/25/2008 62 Female 163 lb 1/28/2009 Other Health Professional France
Primary
Concomitant
Tardive Dyskinesia Other Serious 8/10/2000 57 Male 344 lb 4/3/2009 Other Health Professional United States
Primary
Concomitant
Cardiovascular Disorder Death 65 Male 5/4/2009 Other Health Professional Lebanon
Primary
Secondary
Concomitant
Cardiovascular Disorder Death 3/2/2009 65 Male 143 lb 5/11/2009 Other Health Professional Lebanon
Primary
Secondary
Concomitant
Dermatitis Exfoliative Hospitalization 11/21/2008 Male 5/14/2009 Other Health Professional France
Primary
Concomitant
Lung Disorder Death 1/1/2009 Female 5/15/2009 Physician United Kingdom
Primary
Secondary
Concomitant
Lung Disorder Death 1/1/2009 Female 5/21/2009 Physician United Kingdom
Primary
Secondary
Concomitant
Weight Decreased Death 85 Female 5/18/2009 Lawyer United States
Primary
Concomitant
Troponin Increased Life Threatening 3/1/2009 Male 5/29/2009 Other Health Professional France
Primary
Concomitant
Interacting
Paraplegia Other Serious 1/27/2009 85 6/3/2009 Physician Switzerland
Primary
Concomitant
Interacting
Rhabdomyolysis Life Threatening 1/27/2009 85 Male 6/4/2009 Other Health Professional Switzerland
Primary
Secondary
Concomitant
Subdural Haematoma Hospitalization 4/12/2009 74 Female 6/18/2009 Physician France
Primary
Concomitant
Therapeutic Agent Toxicity Death 76 Female 6/29/2009 United States
Primary
Concomitant
Tachycardia Hospitalization 67 Male 6/30/2009 Lawyer United States
Primary
Concomitant
Hypoglycaemic Coma Hospitalization 4/24/2009 87 Female 7/8/2009 Physician France
Primary
Secondary
Concomitant
Pneumonia Bacterial Hospitalization 3/1/2006 Male 7/10/2009 Consumer United States
Primary
Concomitant
Syncope Life Threatening 5/27/2009 77 Female 7/14/2009 Other Health Professional France
Primary
Concomitant
Vomiting Hospitalization 1/9/2009 84 Male 7/16/2009 Other Health Professional France
Primary
Concomitant
Interacting
Myasthenia Gravis Other Serious 5/8/2008 Female 7/20/2009 Other Health Professional France
Primary
Secondary
Concomitant
Wound Hospitalization 71 Male 7/16/2009 Lawyer United States
Primary
Concomitant
Tremor Hospitalization 5/13/2008 75 Female 7/29/2009 Other Health Professional France
Primary
Concomitant
Weight Decreased Other Serious 7/1/2009 82 Male 7/30/2009 Consumer United Kingdom
Primary
Concomitant
Staphylococcal Infection Hospitalization Female 8/6/2009 Physician France
Primary
Secondary
Concomitant
Vomiting Hospitalization 48 Male 7/21/2009 United States
Primary
Concomitant
Wound Hospitalization 71 Male 8/3/2009 United States
Primary
Concomitant

Drug Data